Cargando…

Psychometric properties of the thyroid-specific quality of life questionnaire ThyPRO in Singaporean patients with Graves’ disease

BACKGROUND: Graves’ disease is the most common cause of hyperthyroidism. It results in accelerated tissue metabolism with multi-organ involvement ranging from cardiovascular to neuropsychological function. This results in a negative impact on the quality of life (QOL) of the individual patient. We a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liew, Huiling, Watt, Torquil, Nan, Luo, Tan, Alvin W. K., Chan, Yiong Huak, Chew, Daniel Ek Kwang, Dalan, Rinkoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266927/
https://www.ncbi.nlm.nih.gov/pubmed/34236563
http://dx.doi.org/10.1186/s41687-021-00309-x
_version_ 1783720037344870400
author Liew, Huiling
Watt, Torquil
Nan, Luo
Tan, Alvin W. K.
Chan, Yiong Huak
Chew, Daniel Ek Kwang
Dalan, Rinkoo
author_facet Liew, Huiling
Watt, Torquil
Nan, Luo
Tan, Alvin W. K.
Chan, Yiong Huak
Chew, Daniel Ek Kwang
Dalan, Rinkoo
author_sort Liew, Huiling
collection PubMed
description BACKGROUND: Graves’ disease is the most common cause of hyperthyroidism. It results in accelerated tissue metabolism with multi-organ involvement ranging from cardiovascular to neuropsychological function. This results in a negative impact on the quality of life (QOL) of the individual patient. We aim to evaluate the psychometric properties of ThyPRO, a Thyroid-related Patient Reported Outcome questionnaire, and validate its use in our multi-ethnic Asian patients with Graves’ hyperthyroidism. METHODS: Forty-seven consecutive Graves’ hyperthyroidism patients answered the ThyPRO questionnaire at baseline and at 4 months after treatment initiation. Data were recorded for thyroid related symptoms and signs, thyroid function tests and thyroid volume. We analyzed the internal consistency using Cronbach’s alpha, construct validity by evaluating relationship between clinical variables and ThyPRO scales, ceiling and floor effects, and responsiveness of ThyPRO to treatment based on Cohen’s effect size. RESULTS: Correlations between individual scale scores and free thyroxine concentrations were moderate and statistically significant: 0.21–0.64 (p <  0.05). There was high internal consistency between the items in this instrument, Cronbach’s alpha > 0.7 for all scales. ThyPRO was responsive to the changes in QOL after treatment (Effect Size: 0.20–0.77) in 9 of the 14 scales including the hyperthyroid symptoms and psychosocial scales (Tiredness, Cognitive complaints, Anxiety, Emotional susceptibility, Impact on Social, Daily and Sex life). CONCLUSION: This study provides evidence that ThyPRO has satisfactory measurement properties in hyperthyroid Graves’ disease patients in Singapore population with the potential to complement clinical care. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-021-00309-x.
format Online
Article
Text
id pubmed-8266927
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82669272021-07-20 Psychometric properties of the thyroid-specific quality of life questionnaire ThyPRO in Singaporean patients with Graves’ disease Liew, Huiling Watt, Torquil Nan, Luo Tan, Alvin W. K. Chan, Yiong Huak Chew, Daniel Ek Kwang Dalan, Rinkoo J Patient Rep Outcomes Research BACKGROUND: Graves’ disease is the most common cause of hyperthyroidism. It results in accelerated tissue metabolism with multi-organ involvement ranging from cardiovascular to neuropsychological function. This results in a negative impact on the quality of life (QOL) of the individual patient. We aim to evaluate the psychometric properties of ThyPRO, a Thyroid-related Patient Reported Outcome questionnaire, and validate its use in our multi-ethnic Asian patients with Graves’ hyperthyroidism. METHODS: Forty-seven consecutive Graves’ hyperthyroidism patients answered the ThyPRO questionnaire at baseline and at 4 months after treatment initiation. Data were recorded for thyroid related symptoms and signs, thyroid function tests and thyroid volume. We analyzed the internal consistency using Cronbach’s alpha, construct validity by evaluating relationship between clinical variables and ThyPRO scales, ceiling and floor effects, and responsiveness of ThyPRO to treatment based on Cohen’s effect size. RESULTS: Correlations between individual scale scores and free thyroxine concentrations were moderate and statistically significant: 0.21–0.64 (p <  0.05). There was high internal consistency between the items in this instrument, Cronbach’s alpha > 0.7 for all scales. ThyPRO was responsive to the changes in QOL after treatment (Effect Size: 0.20–0.77) in 9 of the 14 scales including the hyperthyroid symptoms and psychosocial scales (Tiredness, Cognitive complaints, Anxiety, Emotional susceptibility, Impact on Social, Daily and Sex life). CONCLUSION: This study provides evidence that ThyPRO has satisfactory measurement properties in hyperthyroid Graves’ disease patients in Singapore population with the potential to complement clinical care. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-021-00309-x. Springer International Publishing 2021-07-08 /pmc/articles/PMC8266927/ /pubmed/34236563 http://dx.doi.org/10.1186/s41687-021-00309-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Liew, Huiling
Watt, Torquil
Nan, Luo
Tan, Alvin W. K.
Chan, Yiong Huak
Chew, Daniel Ek Kwang
Dalan, Rinkoo
Psychometric properties of the thyroid-specific quality of life questionnaire ThyPRO in Singaporean patients with Graves’ disease
title Psychometric properties of the thyroid-specific quality of life questionnaire ThyPRO in Singaporean patients with Graves’ disease
title_full Psychometric properties of the thyroid-specific quality of life questionnaire ThyPRO in Singaporean patients with Graves’ disease
title_fullStr Psychometric properties of the thyroid-specific quality of life questionnaire ThyPRO in Singaporean patients with Graves’ disease
title_full_unstemmed Psychometric properties of the thyroid-specific quality of life questionnaire ThyPRO in Singaporean patients with Graves’ disease
title_short Psychometric properties of the thyroid-specific quality of life questionnaire ThyPRO in Singaporean patients with Graves’ disease
title_sort psychometric properties of the thyroid-specific quality of life questionnaire thypro in singaporean patients with graves’ disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266927/
https://www.ncbi.nlm.nih.gov/pubmed/34236563
http://dx.doi.org/10.1186/s41687-021-00309-x
work_keys_str_mv AT liewhuiling psychometricpropertiesofthethyroidspecificqualityoflifequestionnairethyproinsingaporeanpatientswithgravesdisease
AT watttorquil psychometricpropertiesofthethyroidspecificqualityoflifequestionnairethyproinsingaporeanpatientswithgravesdisease
AT nanluo psychometricpropertiesofthethyroidspecificqualityoflifequestionnairethyproinsingaporeanpatientswithgravesdisease
AT tanalvinwk psychometricpropertiesofthethyroidspecificqualityoflifequestionnairethyproinsingaporeanpatientswithgravesdisease
AT chanyionghuak psychometricpropertiesofthethyroidspecificqualityoflifequestionnairethyproinsingaporeanpatientswithgravesdisease
AT chewdanielekkwang psychometricpropertiesofthethyroidspecificqualityoflifequestionnairethyproinsingaporeanpatientswithgravesdisease
AT dalanrinkoo psychometricpropertiesofthethyroidspecificqualityoflifequestionnairethyproinsingaporeanpatientswithgravesdisease